Avidity, LLC, headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in the development of innovative therapeutics. Founded in 2012, the company has made significant strides in advancing its proprietary Avidity Technology™, which uniquely harnesses the power of antibody-drug conjugates to target and treat various diseases, including cancer and genetic disorders. With a strong operational presence across North America and Europe, Avidity has established itself as a leader in the biopharmaceutical sector. The company’s commitment to research and development has led to notable achievements, including successful clinical trials and partnerships with major pharmaceutical firms. Avidity’s core offerings stand out for their precision and efficacy, positioning the company as a key player in the evolving landscape of targeted therapies.
How does Avidity, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Avidity, LLC's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Avidity, LLC, headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Avidity, LLC's climate commitments remain unspecified, and there is no inherited emissions data from a parent or related organisation. The absence of reported emissions and reduction initiatives highlights a potential area for future development in their sustainability strategy.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Avidity, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

